UBS initiated coverage today on the US large-cap pharma with a modestly positive view, saying valuations in the sector more ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE